A Study of 1592U89 in HIV-Infected Children

A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection

NCT00000750 ·Status: COMPLETED ·Phase: PHASE3

Chinese Network of Pediatric Antiretroviral Therapy

NCT01210924 ·Status: COMPLETED

A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women

NCT00000864 ·Status: COMPLETED ·Phase: PHASE1

Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor

NCT00001826 ·Status: COMPLETED

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

NCT00000872 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

NCT00000984 ·Status: COMPLETED ·Phase: PHASE1

UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children

NCT05993767 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV

NCT05006170 ·Status: UNKNOWN ·Phase: PHASE2

Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children

NCT00032669 ·Status: COMPLETED ·Phase: PHASE1

A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease

NCT00000662 ·Status: COMPLETED ·Phase: NA

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV

NCT00307151 ·Status: COMPLETED ·Phase: PHASE2

A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications

NCT00001078 ·Status: COMPLETED ·Phase: NA

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

NCT00234091 ·Status: COMPLETED ·Phase: PHASE3

Dual bNAb Treatment in Children

NCT03707977 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Long-Term Effects of HIV Exposure and Infection in Children

NCT00006304 ·Status: COMPLETED

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

NCT00086359 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers

NCT00000879 ·Status: COMPLETED ·Phase: PHASE1

Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies

NCT00120471 ·Status: COMPLETED ·Phase: PHASE1

Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV

NCT00016783 ·Status: COMPLETED

Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

NCT06517693 ·Status: RECRUITING ·Phase: PHASE1

Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project

NCT02043418 ·Status: ACTIVE_NOT_RECRUITING

Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission

NCT00115648 ·Status: COMPLETED ·Phase: PHASE3

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission

NCT00089505 ·Status: COMPLETED ·Phase: PHASE3

Pediatric Nevirapine Resistance Study

NCT00117728 ·Status: UNKNOWN ·Phase: PHASE3

Pharmacokinetics and Safety of DolutegravIr in Neonate

NCT05590325 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2